Center for Scientific Review; Notice of Meeting, 8093-8094 [2018-03703]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 37 / Friday, February 23, 2018 / Notices
• In Paper 2, Respondent falsified
and/or fabricated the record in:
daltland on DSKBBV9HB2PROD with NOTICES
—Figure 2A (top), by reporting results
for the Rescue condition that did not
originate from experimental
observations
—Figure 3C (right), by reporting results
for the Rescue condition that did not
originate from experimental
observations
Dr. Skau entered into a Voluntary
Settlement Agreement and voluntarily
agreed, beginning on January 25, 2018:
(1) To have her research supervised
for a period of three (3) years;
Respondent agreed to ensure that prior
to the submission of an application for
PHS support for a research project on
which Respondent’s participation is
proposed and prior to Respondent’s
participation in any capacity on PHSsupported research, the institution
employing her must submit a plan for
supervision of Respondent’s duties to
ORI for approval; the plan for
supervision must be designed to ensure
the scientific integrity of Respondent’s
research contribution; Respondent
agreed that she will not participate in
any PHS-supported research until a plan
for supervision is submitted and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon plan for
supervision.
(2) that for a period of three (3) years,
any institution employing her must
submit in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHS
supported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract;
(3) if no supervisory plan is provided
to ORI, to provide certification to ORI
on annual basis that she has not engaged
in, applied for, or had her name
included on any application, proposal,
or other request for PHS funds without
prior notification to ORI;
(4) to exclude herself voluntarily from
serving in any advisory capacity to PHS
including, but not limited to, service on
any PHS advisory committee, board,
and/or peer review committee, or as a
consultant for a period of three (3) years;
and
(5) to the correction or retraction of:
• Cell 167(6):1571–1585, 2016
VerDate Sep<11>2014
20:03 Feb 22, 2018
Jkt 244001
• Proceedings of the National Academy
of Sciences 112(19):E2447–E2456,
2015
Wanda K. Jones,
Interim Director, Office of Research Integrity.
[FR Doc. 2018–03766 Filed 2–22–18; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Drug Development and
Therapeutics.
Date: March 19–20, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Disease
Prevention and Management, Risk Reduction
and Health Behavior Change.
Date: March 19–20, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Westin Grand, 2350 M Street NW,
Washington, DC 20037.
Contact Person: Michael John McQuestion,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
Bethesda, MD 20892, 301–480–1276,
mike.mcquestion@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR17–316:
Biomedical Technology Research Resource
(P41).
Date: March 19, 2018.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
8093
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Mark Caprara, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156,
MSC 7844, Bethesda, MD 20892, 301–435–
1042, capraramg@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: March 19, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Richard G Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Hematology.
Date: March 19–20, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bukhtiar H. Shah, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892, 301–806–
7314, shahb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03702 Filed 2–22–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Center for Scientific
Review Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
E:\FR\FM\23FEN1.SGM
23FEN1
8094
Federal Register / Vol. 83, No. 37 / Friday, February 23, 2018 / Notices
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Center for Scientific
Review Advisory Council.
Date: March 26, 2018.
Time: 7:30 a.m. to 3:30 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health, 6701
Rockledge Drive, Third Floor Conference
Center, Bethesda, MD 20892.
Contact Person: Noni Byrnes, Ph.D., Acting
Deputy Director, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 3030, Bethesda, MD
20892, (301) 435–1023, byrnesn@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into NIH buildings.
Visitors will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
public.csr.nih.gov/aboutcsr/
CSROrganization/Pages/CSRAC.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03703 Filed 2–22–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
daltland on DSKBBV9HB2PROD with NOTICES
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings of the National
Human Genome Research Institute.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
20:03 Feb 22, 2018
Jkt 244001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genomic Resources.
Date: March 5, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, Room 3146,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280, mckenneyk@
mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; DAP (Diversity Action Plan).
Date: March 20, 2018.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, Room 3146,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280, mckenneyk@
mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; LRP (Loan Repayment Plan).
Date: March 22, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, Room 3146,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280, mckenneyk@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: February 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03704 Filed 2–22–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2018–0092]
Certificate of Alternative Compliance
for the GLOBAL PROVIDER
Coast Guard, DHS.
Notification of issuance of a
certificate of alternative compliance.
AGENCY:
ACTION:
The Coast Guard announces
that the Thirteenth District has issued a
certificate of alternative compliance
from the International Regulations for
Preventing Collisions at Sea, 1972 (72
COLREGS), for the M/V GLOBAL
PROVIDER (O.N. CG1427905). We are
issuing this notice because its
publication is required by statute. Due
to the construction and placement of the
aft and forward masts, and required
lights, M/V GLOBAL PROVIDER (O.N.
CG1427905) cannot fully comply with
the light, shape, or sound signal
provisions of the 72 COLREGS without
interfering with the vessel’s design and
construction. This notification of
issuance of a certificate of alternative
compliance promotes the Coast Guard’s
marine safety mission.
DATES: The Certificate of Alternative
Compliance was issued on February 14,
2018.
FOR FURTHER INFORMATION CONTACT: For
information or questions about this
notice call or email LT B. Luke Woods,
Thirteenth District, U.S. Coast Guard;
telephone 206–220–7232, email
Bert.L.Woods@uscg.mil@uscg.mil.
SUPPLEMENTARY INFORMATION: The
United States is signatory to the
International Maritime Organization’s
International Regulations for Preventing
Collisions at Sea, 1972 (72 COLREGS),
as amended. The special construction or
purpose of some vessels makes them
unable to comply with the light, shape,
or sound signal provisions of the 72
COLREGS. Under statutory law 1 and
Coast Guard regulation,2 the vessel’s
owner, builder, operator, or agent of
those vessels may apply for a certificate
of alternative compliance (COAC).3 For
vessels of special construction, the
cognizant Coast Guard District Office
determines whether the vessel for which
the COAC is sought complies as closely
as possible with the 72 COLREGS, and
decides whether to issue the COAC
which must specify the required
alternative installation. If the Coast
Guard issues a COAC, under the
SUMMARY:
1 33
U.S.C. 1605(c).
CFR 81.3.
3 33 CFR 81.5.
2 33
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 83, Number 37 (Friday, February 23, 2018)]
[Notices]
[Pages 8093-8094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03703]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Center for
Scientific Review Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to
[[Page 8094]]
attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: Center for Scientific Review Advisory
Council.
Date: March 26, 2018.
Time: 7:30 a.m. to 3:30 p.m.
Agenda: Provide advice to the Director, Center for Scientific
Review (CSR), on matters related to planning, execution, conduct,
support, review, evaluation, and receipt and referral of grant
applications at CSR.
Place: National Institutes of Health, 6701 Rockledge Drive,
Third Floor Conference Center, Bethesda, MD 20892.
Contact Person: Noni Byrnes, Ph.D., Acting Deputy Director,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3030, Bethesda, MD 20892, (301) 435-1023,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into NIH buildings.
Visitors will be asked to show one form of identification (for
example, a government-issued photo ID, driver's license, or
passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://public.csr.nih.gov/aboutcsr/CSROrganization/Pages/CSRAC.aspx, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-03703 Filed 2-22-18; 8:45 am]
BILLING CODE 4140-01-P
